Baxter's Intravenous Fluids North Cove Plant was impacted in September by Hurricane Helene. Although Baxter implemented a hurricane preparedness plan, a levy breach and bridge collapse forced a complete shutdown. Intravenous fluids are now on allocation as the plant remains shuttered. Multiple actions by the FDA and Baxter are in effect to improve supply for these fluids. Vizient colleagues Katie Korte, VP Assurance and Continuity Team and Kyle Hoelting, Senior Clinical Manager of Drug Information and Shortages join Stacy Lauderdale, Associate Vice president of Evidence-based Medicine today to discuss lessons learned from this and past supply disruptions, ongoing efforts by the FDA to improve supplies and the supply outlook for the next four to eight weeks

Guest speakers: 

Katie Korte, PharmD, MHA

VP Assurance and Continuity Team

Vizient

Kyle Holting, PharmD, BCPS

Senior Clinical Manager of Drug Information and Shortages

Vizient Center for Pharmacy Practice Excellence

Host: 

Stacy Lauderdale, PharmD, BCPS

Associate Vice president of Evidence-based Medicine

Vizient Center for Pharmacy Practice Excellence 

Show Notes: 

[00:57-01:27] Guest’s background information 

[01:28-04:33] Recent supply disruptions

[04:34-05:54] What Vizient has learned from past disruptions

[05:55-09:30] What providers have learned from these shortages

[09:31-13:42] What the FDA is doing to assist with this shortage

[13:43-18:23] What the trajectory of this shortage looks like over the next four to eight weeks

[18:24-19:45] Most important thing to emphasize to our listeners as they continue to handle this fluid shortage

Links | Resources: 

Vizient’s IV push list: Click here

Vizient’s IV fluid conservation strategies: Click here

Baxter’s North Cove facility website: Click here

FDA’s Baxter North Cove facility website: Click here

Subscribe Today!

Apple Podcasts

Amazon Podcasts

Spotify

Android

RSS Feed